IRF5 interactome: search for novel therapeutic targets

IRF5 interactome: search for novel therapeutic targets

Dettagli Bibliografici
Autori principali:	Eames, H, Saliba, D, Wait, R, Udalova, I
Natura:	Conference item
Pubblicazione:	2010

Documenti analoghi

Novel role of IRF5 in transcriptional inhibition of human IL-10 gene expression
di: Krausgruber, T, et al.
Pubblicazione: (2011)

KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages
di: Eames, H, et al.
Pubblicazione: (2012)

A critical role for IRF5 in regulating allergic airway inflammation
di: Byrne, A, et al.
Pubblicazione: (2016)

IRF5:RelA interaction targets inflammatory genes in macrophages.
di: Saliba, D, et al.
Pubblicazione: (2014)

Advances and challenges in targeting IRF5, a key regulator of inflammation
di: Almuttaqi, H, et al.
Pubblicazione: (2018)

IRF5:RelA Interaction Targets Inflammatory Genes in Macrophages
di: David G. Saliba, et al.
Pubblicazione: (2014-09-01)

IRF5 controls macrophage-neutrophil axis in inflammation
di: Udalova, I
Pubblicazione: (2014)

IRF5 is required for late-phase TNF secretion by human dendritic cells.
di: Krausgruber, T, et al.
Pubblicazione: (2010)

Diverse mechanisms of IRF5 action in inflammatory responses
di: Khoyratty, T, et al.
Pubblicazione: (2018)

Diverse mechanisms of IRF5 action in inflammatory responses
di: Khoyratty, T, et al.
Pubblicazione: (2018)

IRF5 as a defining factor of M1 macrophage polarization
di: Krausgruber, T, et al.
Pubblicazione: (2010)

Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation
di: Ryzhakov, G, et al.
Pubblicazione: (2021)

TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer
di: María Paz Saldías, et al.
Pubblicazione: (2021-06-01)

IRF5 is a specific marker of inflammatory macrophages in vivo.
di: Weiss, M, et al.
Pubblicazione: (2013)

M1 MACROPHAGES AND IRF5 EXACERBATE ATHEROSCLEROTIC DISEASE
di: Seneviratne, A, et al.
Pubblicazione: (2013)

Protein Interactome of Amyloid-β as a Therapeutic Target
di: Vladimir F. Lazarev, et al.
Pubblicazione: (2023-02-01)

IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
di: Miriam Weiss, et al.
Pubblicazione: (2013-01-01)

Activation and Function of Interferon Regulatory Factor 5.
di: Ryzhakov, G, et al.
Pubblicazione: (2014)

IRF5 PROMOTES INFLAMMATORY MACROPHAGE POLARIZATION AND TH1/TH17 RESPONSE
di: Krausgruber, T, et al.
Pubblicazione: (2011)

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.
di: Krausgruber, T, et al.
Pubblicazione: (2011)

Identifying unexpected therapeutic targets via chemical-protein interactome.
di: Lun Yang, et al.
Pubblicazione: (2010-03-01)

Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation
di: Grigory Ryzhakov, et al.
Pubblicazione: (2021-11-01)

Regulation of IRF5 activity in inflammatory diseases: novel kinases
di: Almuttaqi, H
Pubblicazione: (2019)

Editorial: STATs and IRFs in Innate Immunity: From Transcriptional Regulators to Therapeutic Targets
di: Chien-Kuo Lee, et al.
Pubblicazione: (2019-08-01)

Unraveling the IGF System Interactome in Sarcomas Exploits Novel Therapeutic Options
di: Caterina Mancarella, et al.
Pubblicazione: (2021-08-01)

Host-HIV-1 Interactome: A Quest for Novel Therapeutic Intervention
di: Ekta Shukla, et al.
Pubblicazione: (2019-09-01)

TRP Channels Interactome in Pancreatic Ductal Adenocarcinoma: A Potential Therapeutic Target
di: Ahmad Taha Khalaf, et al.
Pubblicazione: (2023-03-01)

Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes
di: Xuqin Feng, et al.
Pubblicazione: (2024-12-01)

The Emergence of TRP Channels Interactome as a Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
di: Yuanyuan Wei, et al.
Pubblicazione: (2023-04-01)

An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses
di: Aaron F. Carlin, et al.
Pubblicazione: (2017-11-01)

IRF7 and CTSS are pivotal for cutaneous wound healing and may serve as therapeutic targets
di: Jiali Yin, et al.
Pubblicazione: (2023-08-01)

Interferon-β Production via Dectin-1-Syk-IRF5 Signaling in Dendritic Cells Is Crucial for Immunity to C.albicans
di: delFresno, C, et al.
Pubblicazione: (2013)

Interferon-β production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans.
di: del Fresno, C, et al.
Pubblicazione: (2013)

<it>IRF5</it> gene polymorphisms in melanoma
di: Uccellini Lorenzo, et al.
Pubblicazione: (2012-08-01)

Intracellular IRF5 Dimerization Assay
di: Cherrie Sherman, et al.
Pubblicazione: (2021-05-01)

TBK1 and IRF3 are potential therapeutic targets in Enterovirus A71-associated diseases.
di: Wangquan Ji, et al.
Pubblicazione: (2023-01-01)

TBK1 and IRF3 are potential therapeutic targets in Enterovirus A71-associated diseases
di: Wangquan Ji, et al.
Pubblicazione: (2023-01-01)

Role of interferon regulatory factor 5 in regulation of the human tumor necrosis factor gene expression
di: Krausgrube, T, et al.
Pubblicazione: (2008)

IRF5 guides monocytes toward an inflammatory CD11c+ macrophage phenotype and promotes intestinal inflammation
di: Corbin, AL, et al.
Pubblicazione: (2020)

Phosphorylation of Microglial IRF5 and IRF4 by IRAK4 Regulates Inflammatory Responses to Ischemia
di: Conelius Ngwa, et al.
Pubblicazione: (2021-01-01)